Radiologists look at Vienna

Spring can be felt, though many visitors of ECR 2015 probably only have time to enjoy the floral decorations in the conference center. The program of the conference is packed full of topics that promise exciting days and many discussions.

Session chairman Anwar R. Padhani
Session chairman Anwar R. Padhani
Source: ESR

A major topic of the congress: prostate cancer diagnosis and management. Anwar R. Padhani, consultant radiologist at Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, and Professor of the Institute of Cancer Research, London, thinks that the current situation in prostate cancer diagnosis is a mess for patients: „Men with prostate cancer are both under-diagnosed and over-diagnosed, under-treated and over-treated.“ The reasons for it are manifold. On the one hand, the very controversial PSA level conveys a false sense of safety to many men. Their level may be in the normal range, even though they already have cancer. The opposite is also possible: The value is increased and seems to indicate cancer, but there is no cancer. This is why many men end in OR who instead could have lived without cancer treatment until the rest of their days. On the other hand, biopsy might not always provide an accurate result as well. According to Padhani, a wrong diagnosis occurs in 20 to 30 percent of all cases, because the cancer is simply missed. Radiology therefore focuses on new ultrasonic techniques as well as multi-parameter MRI.

Radiologists have to reconsider ways to treat prostate cancer
For Padhani, the path is clear: “We must change, and for that, we must think differently. Prostate cancer is the last cancer in which imaging is not a key element of the diagnostic pathway. Multi-parametric MRI is becoming a key component of the prostate cancer diagnosis pathway and targeted biopsies of lesions under MRI guidance are likely to become a part of the diagnostic pathway. Tissue preservation, by active surveillance and focal therapy, will reduce the over-treatment burden of localised disease.”

The congress participants are able to get to know which steps this might be in the session NH 9 Image-guided interventions of the prostate on Friday.




Read all latest stories

Related articles


News • Ultrasound, MRI, medical IT

Esaote to showcase AI-enhanced imaging at ECR

Italian biomedical and imaging company Esaote will be present at the ECR radiology congress in Vienna on March 1st - 5th, Expo X5 - Booth 517, to show its latest ultrasound, MRI and medical IT.


News • Sneak peek

ECR 2023: Fujifilm lifts curtain on new products, and more

At the ECR 2023 congress in Vienna, Austria, Fujifilm Europe will unveil new products, host an MRI symposium, and provide opportunities to meet the company's experts.


Article • Earlier, better insights

New developments in whole-body MRI for prostate cancer

Whole-body magnetic resonance imaging (WB-MRI) can detect prostate cancer and inform about treatment response and disease progression earlier and better than other imaging modalities. A Belgian…

Related products



OR Technology · dicomPACS

OR Technology (Oehm und Rehbein GmbH)
Get Up

Accessories / Complementary Systems

Febromed · Get Up

Febromed GmbH & Co. KG

Accessories / Complementary Systems

Schiller · MAGLIFE RT-1

ORCA – OR Cloud

Portal Solutions

OR Technology · ORCA – OR Cloud

OR Technology (Oehm und Rehbein GmbH)
Subscribe to Newsletter